Geoffrey von Maltzahn is an entrepreneur who founded 6 companies, notably: Seres Therapeutics, Inc., Kaleido Biosciences, Inc. and Axcella Health, Inc. Currently, he occupies the position of Chief Executive Officer & Director at Tessera Therapeutics, Inc. (which he founded), Chief Innovation Officer at Indigo Agriculture, Inc. (which he founded in 2013), General Partner for Flagship Pioneering and President & Director at Cobalt Biomedicine, Inc. Dr. Von Maltzahn is also on the board of Kaleido Biosciences, Inc. and Sana Biotechnology, Inc.
In his past career he occupied the position of Chief Technology Officer of Seres Therapeutics, Inc. (he founded the company in 2010) and Vice President-Discovery at Axcella Health, Inc. (he founded the company in 2008) and Vice President-Corporate Development for Essentient, Inc. (a subsidiary of Axcella Health, Inc.).
Geoffrey von Maltzahn received an undergraduate degree and a doctorate from Massachusetts Institute of Technology and a graduate degree from the University of California San Diego.